Insights On Drug Development

31. Sniffing Out Solutions In The Nasal Drug Delivery Revolution 10/7/2025

    As research continues to advance, nasal drug delivery stands at the intersection of innovation and practicality — offering a unique opportunity to expand therapeutic reach while rethinking how medicines are administered and experienced.

32. What Are The Keys To Making Rare Disease Drug Development Sustainable? 9/30/2025

    This roundtable weaves together diverse perspectives, providing a multifaceted look at what it will take to create a sustainable path forward in rare disease drug development.

33. Utilizing Flow Cytometry For Humoral Immunogenicity Testing: Cell & Gene Therapy 9/29/2025

    Discover strategies to overcome immunogenicity challenges in cell and gene therapies, with a focus on harnessing flow cytometry to enhance ADA and NAb assay development, strengthen validation, and ensure regulatory readiness.

34. Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency 9/25/2025

    Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

35. Overcoming Unique Client Challenges With A Strong Collaborative Partnership 9/23/2025

    Through close collaboration, proactive communication, and agile project management, our partnership accelerated an oncology program and helped overcome complex preclinical hurdles.

36. Advancing ADC Development: Overcoming Preclinical Challenges 9/23/2025

    Learn how to accelerate the journey of ADC candidates from early discovery to clinical development, enhancing the success rate of translating preclinical discoveries into effective cancer treatments.

37. BxPC-3: Evaluating Responses To Standard Therapeutic Agents 9/23/2025

    Review multiple studies utilizing the BxPC-3 human pancreatic cancer model in subcutaneous (SC) NSG and NSG-dKO mouse models, evaluating a range of standard agents, vehicles, and delivery methods.

38. Not A Trick Question: How Do You Know When You Have Adequately Established A Reliable Supply Chain? 9/23/2025

    Leave it to an Outsourced Pharma Live digital discussion to ask the questions others leave out. How much de-risking is too much? When can you sleep at night knowing your supply chains are as they should be, and you can fully rely on them? Oh, and we answer questions such as these as well.

39. The Criticality Of Biannual Overview Meetings With Your Suppliers 9/23/2025

    Daily communication and periodic project- and individual team-level meetings are important. But according to one outsourcing professional with decades of experience, do not overlook the importance of Biannual (or Quarterly) meetings to ensure outsourcing success.

40. When To Consolidate CDMOs ... And When You Shouldn't 9/23/2025

    A supply chain expert with decades of experience says that "from a a pure supply chain perspective, we always try to "have universal drug substance, universal drug product and try to differentiate in packaging." But that doesn't always work out ...